| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Levy Howard is a Chief Medical Officer at GYRE THERAPEUTICS, INC.. Recent SEC Form 4 filings include 4 buys and 1 sell.
Estimated insider holdings value: $4K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2021 | GYRE Gyre Therapeutics, Inc. | Chief Medical Officer | Buy | 639 | $3.62 | $2,313.18 | New | -26.5% | -57.0% | |
| Feb 9, 2021 | GYRE Gyre Therapeutics, Inc. | Chief Medical Officer | Buy | 1,670 | $4.81 | $8,032.70 | +7.7% | - | - | |
| Aug 10, 2020 | GYRE Gyre Therapeutics, Inc. | Chief Medical Officer | Buy | 1,768 | $4.81 | $8,504.08 | +70.7% | - | - | |
| Mar 16, 2020 | GYRE Gyre Therapeutics, Inc. | Chief Medical Officer | Buy | 2,500 | $4.05 | $10,131.50 | New | - | - | |
| Nov 16, 2018 | GYRE Gyre Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 173 | $11.00 | $1,903.00 | -2.2% | - | - |